Detalles de la búsqueda
1.
Development of a conditional in vivo model to evaluate the efficacy of small molecule inhibitors for the treatment of Raf-transformed hematopoietic cells.
Cancer Res
; 65(21): 9962-70, 2005 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16267021
2.
Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells.
Oncogene
; 23(47): 7810-20, 2004 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-15361836
3.
Raf promotes human herpesvirus-8 (HHV-8/KSHV) infection.
Oncogene
; 23(30): 5227-41, 2004 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15122343
4.
Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells.
Oncogene
; 22(16): 2478-92, 2003 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-12717425
5.
Synergy between PI3K/Akt and Raf/MEK/ERK pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cells.
Cell Cycle
; 3(3): 372-9, 2004 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-14726697
6.
Ability of the activated PI3K/Akt oncoproteins to synergize with MEK1 and induce cell cycle progression and abrogate the cytokine-dependence of hematopoietic cells.
Cell Cycle
; 3(4): 503-12, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15004527
7.
B-raf and insulin synergistically prevent apoptosis and induce cell cycle progression in hematopoietic cells.
Cell Cycle
; 3(2): 189-96, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-14712088
8.
Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review).
Int J Oncol
; 22(3): 469-80, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12579299
9.
Fibroblastic, hematopoietic, and hormone responsive epithelial cell lines and culture conditions for elucidation of signal transduction and drug resistance pathways by gene transfer.
Methods Mol Biol
; 218: 185-201, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12616722
10.
Elucidation of signal transduction pathways by transfection of cells with modified oncogenes.
Methods Mol Biol
; 218: 203-20, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12616723
11.
Elucidation of signal transduction pathways by retroviral infection of cells with modified oncogenes.
Methods Mol Biol
; 218: 221-52, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12616724
12.
Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy.
Cell Cycle
; 9(9): 1839-46, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20436269
13.
The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy.
Cell Cycle
; 9(9): 1781-91, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20436278
14.
Dominant roles of the Raf/MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs.
Cell Cycle
; 9(8): 1629-38, 2010 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20372086
15.
Solubility and bioactivity of the Pseudomonas quinolone signal are increased by a Pseudomonas aeruginosa-produced surfactant.
Infect Immun
; 73(2): 878-82, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15664929
16.
The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what's genetics got to do with it?
Expert Opin Ther Targets
; 9(5): 1009-30, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16185155
17.
Effects of endogenous epidermal growth factor receptor signaling on DNA synthesis and ERK activation in a cytokine-dependent hematopoietic cell line.
Cell Cycle
; 4(6): 818-21, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15908804
18.
Conditional EGFR promotes cell cycle progression and prevention of apoptosis in the absence of autocrine cytokines.
Cell Cycle
; 4(6): 822-30, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15917660
Resultados
1 -
18
de 18
1
Próxima >
>>